Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer’s disease in a cross-sectional multi-cohort study

Código QR

Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer’s disease in a cross-sectional multi-cohort study

Abstract Normative modelling is an emerging method for quantifying how individuals deviate from the healthy populational pattern. Several machine learning models have been implemented to develop normative models to investigate brain disorders, including regression, support vector machines and Gaussi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Walter H. L. Pinaya, Cristina Scarpazza, Rafael Garcia-Dias, Sandra Vieira, Lea Baecker, Pedro F da Costa, Alberto Redolfi, Giovanni B. Frisoni, Michela Pievani, Vince D. Calhoun, João R. Sato, Andrea Mechelli
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/232c67a78bc8428fb037c3b63039cf5c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
por: Xiong Jiang, et al.
Publicado: (2021)

A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
por: Leigh A Johnson, et al.
Publicado: (2013)

Impaired comprehension of metaphorical expressions in very mild Alzheimer’s disease
por: Fujimoto N, et al.
Publicado: (2019)

Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
por: Paul Loyd Wheeler, et al.
Publicado: (2021)

Whole-brain functional networks in cognitively normal, mild cognitive impairment, and Alzheimer's disease.
por: Eun Hyun Seo, et al.
Publicado: (2013)

Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer’s disease
por: Xiao-Yan Ge, et al.
Publicado: (2021)

Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
por: Wenjuan Rui, et al.
Publicado: (2021)

Effects of Meditation on Structural Changes of the Brain in Patients With Mild Cognitive Impairment or Alzheimer’s Disease Dementia
por: Madhukar Dwivedi, et al.
Publicado: (2021)

Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment
por: Ozkan S, et al.
Publicado: (2013)

Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion.
por: Han Li, et al.
Publicado: (2014)

Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology
por: Sacco G, et al.
Publicado: (2012)

Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
por: Shizuo Hatashita, et al.
Publicado: (2013)

Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.
por: Eugenia Trushina, et al.
Publicado: (2013)

Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease
por: Dongwha Sohn, et al.
Publicado: (2018)

Donepezil for mild cognitive impairment in Parkinson’s disease
por: Kyoungwon Baik, et al.
Publicado: (2021)

Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
por: Samtani MN, et al.
Publicado: (2014)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)
por: Harris P, et al.
Publicado: (2015)

Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer’s disease
por: Li W, et al.
Publicado: (2016)

Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment.
por: Gretel Sanabria-Diaz, et al.
Publicado: (2013)

MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.
por: Moeko Noguchi-Shinohara, et al.
Publicado: (2021)

Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer's disease patients: A meta-analysis.
por: Jingwen Hui, et al.
Publicado: (2021)

Resting-state functional reorganisation in Alzheimer’s disease and amnestic mild cognitive impairment: protocol for a systematic review and meta-analysis
por: Diyang Lyu, et al.
Publicado: (2021)

MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer’s disease
por: Moeko Noguchi-Shinohara, et al.
Publicado: (2021)

Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
por: Albert Dayor Piersson, et al.
Publicado: (2021)

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
por: Sebastian Palmqvist, et al.
Publicado: (2012)

Relationship between Amyloid-β Deposition and the Coupling between Structural and Functional Brain Networks in Patients with Mild Cognitive Impairment and Alzheimer’s Disease
por: Hui Zhang, et al.
Publicado: (2021)

Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
por: Wei-Ju Lee, et al.
Publicado: (2018)

Spatial Pattern Separation Testing Differentiates Alzheimer’s Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Martina Laczó, et al.
Publicado: (2021)

TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease: A Proof-of-Concept Six Years Prospective Study
por: Florinda Ferreri, et al.
Publicado: (2021)

Is Non-invasive brain stimulation an effective tool for cognitive enhancement in Alzheimer’s disease and mild cognitive impairment? Results from the meta-analysis
por: Patrik Šimko, et al.
Publicado: (2021)

Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
por: Yumi Umeda-Kameyama, et al.
Publicado: (2017)

An innovative intervention for the treatment of cognitive impairment–Emisymmetric bilateral stimulation improves cognitive functions in Alzheimer’s disease and mild cognitive impairment: an open-label study
por: Guerriero F, et al.
Publicado: (2015)

Is the left uncinate fasciculus associated with verbal fluency decline in mild Alzheimer's disease?
por: Kljajevic Vanja, et al.
Publicado: (2016)

Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer’s disease
por: Pooja Jadiya, et al.
Publicado: (2019)

Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.
por: Erika J Lampert, et al.
Publicado: (2013)

Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer’s disease: a randomized controlled clinical trial
por: Zhao J, et al.
Publicado: (2018)

Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer’s disease
por: Celina S. Liu, et al.
Publicado: (2021)

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
por: Ferris SH, et al.
Publicado: (2013)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
por: Maynard SD, et al.
Publicado: (2013)